Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WHO Steps Up Drive To Build Local Drug & Vaccine Production In Lower-Income Countries

Executive Summary

The COVID-19 pandemic has underlined the need for less well-resourced countries to improve access to medicines, vaccines, medical devices and other health products by building their own production capacities.

You may also be interested in...



How Africa Can Meet Its Daunting Production Challenge For Critical Disease Vaccines

Africa is taking steps to massively increase its vaccine production capacity and reduce its heavy dependence on other countries for supplies. Muthoni Wanyeki of the Open Society Foundations explained to the Pink Sheet how COVID-19 has highlighted the need for action and why it is important to keep up the momentum achieved so far.

Aspen Setback Illustrates Need For Africa To Build Up Vaccines Market

A coordinated effort will be needed if Africa is to increase its manufacturing capacity and ensure a market for domestically produced vaccines.

EU Preparing Guidance On Synthetic Oligonucleotides & Peptides

Two new quality guidelines are needed to address the increase in applications for clinical trials and marketing authorizations of oligonucleotide- and peptide-based medicines, says the EU regulator.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS146884

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel